NLS Pharmaceutics (NLSP) said Friday that Kadimastem's shareholders have approved the company's merger with NLS.
NLS said it is also planning to hold a shareholder meeting for final approval of the deal.
NLS shares were up 45% in recent trading.
Price: 2.88, Change: +0.90, Percent Change: +45.45
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。